In pharmacology, which statement best defines a drug's half-life?

Prepare for the Virginia HESI Level 4 Test with an array of study materials including flashcards and multiple choice questions. Each question comes with hints and detailed explanations to assist in your exam preparation. Get set to ace your test!

Multiple Choice

In pharmacology, which statement best defines a drug's half-life?

Explanation:
Half-life is the time it takes for the plasma concentration of a drug to drop by 50 percent. This reflects how quickly the body eliminates the drug under typical first-order kinetics, where a constant fraction is removed per unit time. Knowing the half-life helps you predict how long a drug stays in the body and guides dosing schedules and time to reach steady-state—roughly after four to five half-lives. A useful relation is t1/2 ≈ 0.693 × Vd / CL, linking half-life to how much drug is distributed in the tissues (volume of distribution) and how quickly it’s cleared (clearance). The idea of waiting until the drug is cleared completely isn’t accurate in normal clinical scenarios; elimination continues toward zero but never has a fixed moment of complete disappearance. The interval between doses that keeps levels steady describes dosing frequency, not the half-life. And the duration of pharmacologic activity isn’t guaranteed by half-life alone—activity depends on the drug’s concentration relative to its effect threshold, receptor interactions, and pharmacodynamics.

Half-life is the time it takes for the plasma concentration of a drug to drop by 50 percent. This reflects how quickly the body eliminates the drug under typical first-order kinetics, where a constant fraction is removed per unit time. Knowing the half-life helps you predict how long a drug stays in the body and guides dosing schedules and time to reach steady-state—roughly after four to five half-lives. A useful relation is t1/2 ≈ 0.693 × Vd / CL, linking half-life to how much drug is distributed in the tissues (volume of distribution) and how quickly it’s cleared (clearance).

The idea of waiting until the drug is cleared completely isn’t accurate in normal clinical scenarios; elimination continues toward zero but never has a fixed moment of complete disappearance. The interval between doses that keeps levels steady describes dosing frequency, not the half-life. And the duration of pharmacologic activity isn’t guaranteed by half-life alone—activity depends on the drug’s concentration relative to its effect threshold, receptor interactions, and pharmacodynamics.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy